Novelix Pharmaceuticals Performance
- Today's Low
- ₹63
- Today's High
- ₹70
- 52 Week Low
- ₹38
- 52 Week High
- ₹92
- Open Price₹65
- Previous Close₹67
- Volume4,372
- 50 DMA₹68.20
- 100 DMA₹63.90
- 200 DMA₹57.00
Novelix Pharmaceuticals Chart
Investment Returns
- Over 1 Month -20.23%
- Over 3 Month + 19.34%
- Over 6 Month + 23.39%
- Over 1 Year + 46.45%
Smart Investing Starts Here Start SIP with Novelix Pharmaceuticals for Steady Growth!
Novelix Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 46.2
- PEG Ratio
- 0
- Market Cap Cr
- 118
- P/B Ratio
- 2.7
- Average True Range
- 5
- EPS
- 1.5
- Dividend Yield
- 0
- MACD Signal
- -1.1
- RSI
- 37.4
- MFI
- 13.75
Latest Stock News Updates
Submission of Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018
- BSE India
- 1 day 22 hours ago
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Vupparapalli Chandrasekhar Reddy & Others
- BSE India
- 4 days 16 hours ago
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Srinidhi Fine - Chemicals LLP & Others
- BSE India
- 4 days 16 hours ago
Novelix Pharmaceuticals Financials
Novelix Pharmaceuticals Technicals
EMA & SMA
- Bearish Moving Average 9
- Bullish Moving Average 7
- 20 Day
- ₹70.80
- 50 Day
- ₹68.20
- 100 Day
- ₹63.90
- 200 Day
- ₹57.00
Resistance and Support
- R3 74.30
- R2 72.10
- R1 67.70
- S1 61.00
- S2 58.80
- S3 54.40
Novelix Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-06-04 | Preferential Issue of shares & Others | Inter-alia, to consider 1. Approve the Draft Notice of EGM. 2.Fix the day, date, time & venue of EGM. 3. Appoint Scrutinizer for conducting E- voting process for EGM. 4. Other business matters. |
| 2026-05-29 | Audited Results & Preferential issue | |
| 2026-02-12 | Quarterly Results | |
| 2025-11-13 | Quarterly Results | |
| 2025-08-14 | Quarterly Results & A.G.M. |
About Novelix Pharmaceuticals
Novelix Pharmaceuticals is into the business of Trading of Pharmaceuticals and related products and is into the business of trading of shares and securities. View More- NSE Symbol
- TRIMURTHI
- BSE Symbol
- 536565
- ISIN
- INE314I01036
Similar Stocks to Novelix Pharmaceuticals
Popular Stocks
Novelix Pharmaceuticals FAQs
Novelix Pharmaceuticals share price is ₹67 As on 18 July, 2026 | 11:48
The Market Cap of Novelix Pharmaceuticals is ₹118 Cr As on 18 July, 2026 | 11:48
The P/E ratio of Novelix Pharmaceuticals is 46.2 As on 18 July, 2026 | 11:48
The PB ratio of Novelix Pharmaceuticals is 2.7 As on 18 July, 2026 | 11:48
The 52 week High & Low of Novelix Pharmaceuticals is ₹92/₹38 respectively As on 18 July, 2026 | 11:48
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.